Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors.
Neuroprotective effects of chrysin: From chemistry to medicine.
Neuroimmunological diseases and pregnancy.
Attenuation of corpus callosum axon myelination and remyelination in the absence of circulating sex hormones.
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis.
Quantitative oxygen extraction fraction from 7-Tesla MRI phase: reproducibility and application in multiple sclerosis.
Fluoxetin Upregulates Connexin 43 Expression in Astrocyte.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Meta-analysis of prevalence.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Concurrent Quantification of Tryptophan and Its Major Metabolites.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Interferon beta-related nephropathy and interstitial lung disease: a new association and a long-term warning.
The onset location of neuromyelitis optica spectrum disorder predicts the location of subsequent relapses.
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
[The quality of nighttime sleep in patients with multiple sclerosis].
Rituximab combination therapy in relapsing multiple sclerosis.
Role of Vitamin D in the Onset, Progression and Severity of Multiple Sclerosis.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
The role of angiogenesis in the pathology of multiple sclerosis.
Elevated Neutrophil Lymphocyte Ratio in Recurrent Optic Neuritis.
MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients.
Glial influence on the blood brain barrier.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Pages
« first
‹ previous
…
332
333
334
335
336
337
338
339
340
…
next ›
last »